Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct pulmonary vascular disease caused by chronic obstruction of major pulmonary arteries that is amenable to cure by pulmonary ...

Hungary summoned the Ukrainian ambassador on Thursday, after a report that a Hungarian-Ukrainian dual citizen was beaten to death during forced mobilisation, an allegation Ukraine's army rejected, ...

The fusion of multimodal medical data is crucial for helping doctors make accurate treatment decisions. For example, combining Computed Tomography Pulmonary Angiography (CTPA) with Electronic Health ...

Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...

Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.

The ECG is abnormal in over 70% of patients with pulmonary embolism. Certain ECG abnormalities have been observed to return to normal after treatment. This case report describes an instructive ECG ...

Despite significant progress in treatment methods in recent years, acute pulmonary embolism (PE) remains the third leading cause of cardiovascular‐related deaths worldwide. 1, 2 Although >90% patients ...

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days in May, Dr Aurélie Dehaene, radiologist at European Hospital in Marseille, ...

Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device exemption study was ...

The trial evaluates the Hēlo™ PE Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism (PE)—a life-threatening condition caused by blood clots in the lungs.